Asbestos Diseases Research Foundation
ABN 79 121 168 867
The Asbestos Diseases Research Foundation (ADRF) was established in 2006 as a charitable, not-for-profit organisation dedicated to assist and support the research efforts into asbestos and other dust-related diseases. The Foundation established and operates the Asbestos Diseases Research Institute (ADRI) a dedicated research institute. The ADRF continues to support ADRI by attracting financial support from companies and individuals.
The objects for which the Foundation is established are:
- to promote, sponsor and facilitate research and healthcare delivery among those individuals and communities exposed to asbestos or other dusts or suffering from asbestos-related or other dust-related diseases;
- to provide leadership and excellence in asbestos-related and dust-related diseases research activities;
- to promote awareness of the special circumstances experienced by those exposed to asbestos or other dusts which can lead to potential or actual asbestos-related or other dust-related diseases;
- to promote, sponsor and facilitate asbestos-related and dust-related diseases education and training in relevant health disciplines;
- to further knowledge of medicine and science by promoting the conduct of research in the field of asbestos-related and other dust-related diseases;
- to achieve a better understanding of the nature and causes of asbestos-related and dust-related human diseases and afflictions;
- to improve methods of preventing, diagnosing and treating those diseases and afflictions; and
- where possible, to apply its research and other activities, either directly or indirectly, to the development of relevant products and treatments; preventative strategies and practices; and educational programs and materials for asbestos-related and other dust-related diseases.
The Foundation must pursue its objectives principally in Australia.
The Board of the Foundation consists of the independent chairperson invited by the Minister for Industrial Relations, two members from the Workers Compensation Dust Diseases Board; nominees from the University of Sydney, ANZAC Health & Medical Research Foundation, Sydney Local Health District, Asbestos Diseases Foundation of Australia Inc., Unions NSW, and past and present manufacturers and suppliers of asbestos or dust-containing goods. In addition, the Board has appointed a further member, being the Research Director of the Institute.
The Asbestos Diseases Research Foundation is a registered charity with the Australian Charities and Not-for-profits Commission (ACNC).
Mr Peter Tighe
Peter Tighe was the CEO of the Asbestos Safety and Eradication Agency (ASEA), appointed by the Minister of Employment as Statutory Officer for a period of five years until August 2018. ASEA was established to implement the first National Strategic Plan for the management and eradication of asbestos and asbestos containing material. Peter was National Secretary of the Communications Electrical and Plumbing Union (CEPU) and Divisional Secretary of the Electrical Trades Union (ETU). Peter was an Executive member of the Australian Council of Trade Unions (ACTU) and a ministerial appointee to Safe Work Australia. He has also served on a variety of vocational boards including the Central Trades Committee of Training Recognition Australia and was a committee member of the Ministerial Council for Tertiary Education and Employment Apprentices Action Group. He was also a member of the Climate Change and Energy Efficiency’s NGO Climate change roundtable. Peter was the Chair of the National Electrical and Electronic Industry Training Council and E-Profiling Pty Ltd; Chair and Deputy Chair of Connect Superannuation (now merged with C+Bus); and Trustee and Director on the Board of the Investment Committee of CBUS Superannuation. He is currently Deputy Chair of EE-Oz Energy Skills Australia and a member of the Board of Exemplar Systems Pty Ltd and Exemplar Learning Pty Ltd.
Appointed: 25 February 2019
Dr Chris Colquhoun FAFOEM
Nominated by Dust Diseases Authority
Dr Chris Colquhoun is an Occupational and Environmental physician and is the Chief Medical
Officer of icare (Insurance and Care NSW). He has experience in clinical and corporate settings with proven skills across areas including clinical governance, health surveillance, hazardous substance and dust diseases health monitoring, fitness for work assessments, workplace injury prevention and management, healthcare management and leadership, strategic planning and clinical research. Dr Colquhoun was the Regional Medical Director (NSW/ACT/VIC) for Sonic HealthPlus, Australia’s leading provider of occupational health care and general medical services, from 2014–2016. He also worked for Medibank Health Solutions, the health management and telehealth services arm of the private health insurer Medibank Private from 2008–2014, becoming the Lead Medical Officer of the Commonwealth (2012–2014). He served as Senior Medical Officer of the Commonwealth, Immigration Services, Health Services Australia, from 2005–2007 and had a previous appointment as Intensive Care/Critical Care Registrar with the South Eastern Sydney Area Health Services from 2002–2004.
Appointed: 15 June 2020
Dr Teresa Anderson AM, FIPAA
Nominated by the Sydney Local Health District
Dr Teresa Anderson is the Chief Executive of Sydney Local Health District, one of the leading public health services in Australia. She has more than 35 years of experience as a clinician and health service executive. She has a well-established reputation for implementing strategies to foster innovation and best practice, supporting collaboration and building partnerships. She is an internationally recognised Speech Pathologist and is passionate about developing programs and services to support and improve the health and wellbeing of all people in the community. In 2018 Dr Anderson was appointed a Member of the Order of Australia (AM). Dr Anderson is a Vice President and has been made a Fellow of the NSW Institute of Public Administration Australia, is a member of seven Medical Research, Health and PHN boards and is an active member of the Sydney Health Partners Governing Council and Executive Management Group, one of the first four centres in Australia designated by the NHMRC as an Advanced Health Research Translation Centre.
Appointed 21 May 2018
Professor Stephen Clarke OAM
Nominated by the Asbestos Diseases Foundation of Australia Inc.
Professor Stephen Clarke is a medical oncologist at Royal North Shore Hospital in Sydney and Professor of Medicine at the University of Sydney. After completing his medical oncology training at RNSH, St. Leonards, Stephen undertook a PhD at the Institute of Cancer Research/Royal Marsden Cancer Hospital, before returning to Australia in 1994. He was Professor of Medicine at Concord Hospital from 2004-2010.He has clinical and research interests in thoracic and GI cancers, including mesothelioma. He has had 2 PhD student completions in mesothelioma including Steven Kao and Anthony Linton and has one current student (Tamkin Ahmadzada) undertaking research in microvesicles in mesothelioma. His research has achieved over $26 million in competitive grant funding that has led to over 330 publications, which have been cited 20,000 times. Stephen is an Oncology Advisor to the Department of Veteran’s Affairs and is a Member of the Repatriation Pharmaceutical Review Committee.
Appointed: 10 February 2020
Mr Paul Bastian
Nominated by Unions NSW
Paul Bastian was previously the National Secretary of the Australian Manufacturing Workers’ Union (AMWU) retiring from the position in September 2020. Paul commenced his employment with the AMWU in 1981 and in 1997 was elected State Secretary of the NSW Branch. He is a shipwright by trade and completed a Law Degree while studying part-time at the University of Technology, Sydney. Paul has worked throughout the manufacturing industry, in the construction, shipbuilding and metal industries, in both metropolitan and regional areas of NSW. He represented the AMWU on a number of Boards and Committees, including ACTU Executive. Paul was a member of the Asbestos Management Review Advisory Group, as well as once being on the Boards of AustralianSuper, APHEDA, the NSW Manufacturing Council, and the NSW Workers Compensation Advisory Council. He has a long history of involvement with community and union campaigns against asbestos and has represented the AMWU and IndustriALL Global Union (previously known as the International Metalworkers Federation) at numerous international asbestos conferences.
Appointed: 10 February 2020
Professor Laurent Rivory
Nominated by The University of Sydney
Professor Rivory is the Pro-Vice-Chancellor (Research) at the University of Sydney. His role focuses on the areas where cross-faculty engagement and external partnerships are integral to the academic enterprise. His responsibilities include large-scale collaborations such as the Charles Perkins Centre and the Brain and Mind Centre, the Core Research Facilities and the management of external partnerships, particularly in health. Professor Rivory is widely recognised for his research in cancer drug pharmacology and has extensive experience in the management of key research programmes in virology, immunology, cancer, RNA therapeutics and diagnostics. He has served as Senior Research Director, Research and Development, at Johnson and Johnson Research and was Director of the Research Strategy Office at the University of New South Wales. He has also had previous appointments as Clinical Senior Lecturer at the University of Sydney and as Head of the Pharmacology Laboratory, Sydney Cancer Centre at Royal Prince Alfred Hospital.
Appointed: 7 December 2018
Professor Christine Jenkins AM
Nominated by the ANZAC Health and Medical Research Foundation
Christine is head of the Respiratory Group at The George Institute for Global Health; Clinical Professor at Concord Clinical School and University of Sydney; and Professor of Respiratory Medicine at UNSW Sydney. She is a thoracic physician with a clinical and research focus on the management of airways disease and retired from her position as staff specialist in thoracic medicine at Concord Hospital in December 2020. Christine has led many sponsored and investigator-initiated clinical trials in asthma and COPD and in her role at The George Institute she supervises a research team and PhD students, implementing several trials in asthma, COPD and pulmonary rehabilitation in Australia, New Zealand and Asia. She is active in advocacy and leadership for lung health in Australia and is a member of several global advisory boards for the pharmaceutical industry. She has previously chaired the National Asthma Campaign, the TSANZ, the National Asthma Reference Group which advised government on asthma as a National Health Priority, the Respiratory Conditions Advisory Group of AIHW, and The Thoracic and Sleep Medicine Review of the MBS. She is the current chair of the Board of the Lung Foundation of Australia and is a member of the National Dust Diseases Task Force.
Appointed: 8 February 2021
Professor Ken Takahashi
Ken Takahashi was Professor of Environmental Epidemiology and Director of the WHO Collaborating Centre for Occupational Health at the University of Occupational and Environmental Health (UOEH), Japan. Ken graduated from the School of Medicine, Keio University in 1983 (MD), and after completing a 2-year residency in surgery, he received a PhD from UOEH and MPH from the University of Pittsburgh. He engages in epidemiologic research of occupational diseases, with special interest on occupational lung diseases, and asbestos-related diseases in particular. He served as consultant/advisor to the WHO and ILO on a number of occasions, examiner/advisor to academic institutes in several Asian countries, is a former Board Member of the International Commission of Occupational Health and former President of the Asian Association for Occupational Health. He currently serves as the WHO Expert on Chemical Safety/Environmental Epidemiology (International Health Regulations) and is a Fellow and Executive Council Member of the Collegium Ramazzini. He received the Jorma Rantanen Award from the Finnish Institute of Occupational Health in 2011 and the Selikoff Lifetime Achievement Award from the Asbestos Disease Awareness Organization (NGO in USA) in 2014. In February 2017 the Asbestos Diseases Research Foundation and The University of Sydney recruited Ken Takahashi to the position of ADRI Director and Professor, Sydney Medical School.
Appointed: 1 February 2017
Ms Victoria Keena
Company Secretary - Interim
Ms Victoria Keena is the Executive Officer of the Asbestos Diseases Research Institute and has extensive work experience in medical research institutes, and assists the Director in the management and development of the Institute in order to achieve the strategic and operational objectives. She was the General Manager of the Woolcock Institute of Medical Research until 2007. Victoria is also the interim Company Secretary of Asbestos Diseases Research Foundation.
Appointed: 15 April 2019